Below are the most recent publications written about "Recombinant Proteins" by people in Profiles.
-
Reddy JV, Leibiger T, Singh SK, Lee KH, Papoutsakis E, Ierapetritou M. A Novel, Site-Specific N-Linked Glycosylation Model Provides Mechanistic Insights Into the Process-Condition Dependent Distinct Fab and Fc Glycosylation of an IgG1 Monoclonal Antibody Produced by CHO VRC01 Cells. Biotechnol Bioeng. 2025 Apr; 122(4):761-778.
-
Jacobs IJ, Obiri-Yeboah D, Stabach PR, Braddock DT, Li Q. Novel treatment for PXE: Recombinant ENPP1 enzyme therapy. Mol Ther. 2024 Nov 06; 32(11):3815-3820.
-
Levy AT, Weingarten SJ, Robinson K, Suner T, McLaren RA, Saad A, Al-Kouatly HB. Recombinant erythropoietin for the treatment of iron deficiency anemia in pregnancy: A systematic review. Int J Gynaecol Obstet. 2025 Jan; 168(1):35-42.
-
Guillet B, Yan S, Hooper B, Drelich D, Steenkamp J, Tomic R, Mancuso ME. Matching-Adjusted Indirect Comparison of Recombinant Factor?IX Albumin Fusion Protein Versus Recombinant Factor?IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia?B. Adv Ther. 2024 02; 41(2):649-658.
-
Kucine N, Jessup JA, Cooper TM, Urbanski RW, Kolb EA, Resar LMS. Position paper: The time for cooperative group study of ropeginterferon alfa-2b in young patients with myeloproliferative neoplasms is now. Pediatr Blood Cancer. 2023 10; 70(10):e30559.
-
Devich R, Neuendorff NR, Frazier OH, Eisen HJ, Dowling R, Freundt M. Hematopoietic Stimulation During Impella 5.5 Support to Avoid Transfusions in a Jehovah's Witness. ASAIO J. 2023 08 01; 69(8):e384-e387.
-
Hamaker NK, Lee KH. High-efficiency and multilocus targeted integration in CHO cells using CRISPR-mediated donor nicking and DNA repair inhibitors. Biotechnol Bioeng. 2023 09; 120(9):2419-2440.
-
Lee LA, Barrick SK, Buvoli AE, Walklate J, Stump WT, Geeves M, Greenberg MJ, Leinwand LA. Distinct effects of two hearing loss-associated mutations in?the sarcomeric myosin MYH7b. J Biol Chem. 2023 05; 299(5):104631.
-
Garcia Garcia C, Patkar SS, Wang B, Abouomar R, Kiick KL. Recombinant protein-based injectable materials for biomedical applications. Adv Drug Deliv Rev. 2023 02; 193:114673.
-
Boruah JLH, Venkatesh G, Nagarajan S, Senthilkumar D, Bhatia S, Tosh C, Kumar M, Rai R, Tripathi S, Shukla S, Dubey CK, Singh VP. Immunogenicity and cross-protective efficacy of recombinant H5HA1 protein of clade 2.3.2.1a highly pathogenic H5N1 avian influenza virus expressed in E.coli. Microb Pathog. 2022 Jul; 168:105605.